BCL2 Inhibition: A New Paradigm for the Treatment of AML and Beyond

por Wei, Andrew H., Roberts, Andrew W.
Publicado 2023

Assessing the Present State and Potential of Medicaid Controlled Substance Lock-In Programs

por Roberts, Andrew W., Skinner, Asheley Cockrell
Publicado 2014

Reimbursement Policies for Diabetes Prevention Program (DPP): Implications for Racial and Ethnic Health Disparities

por Formagini, Taynara, Brooks, Joanna V., Jacobson, Lisette T., Roberts, Andrew W.
Publicado 2021

Medicaid prescription limits and their implications for naloxone accessibility

por Roberts, Andrew W., Look, Kevin A., Trull, Grace, Carpenter, Delesha M.
Publicado 2021

Sleep Quality and Sleep Behaviors in Varsity Athletes: A Pilot Study

por Rebello, Lyndon J., Roberts, Andrew W., Fenuta, Alyssa M., Cote, Anita T., Bodner, Michael E.
Publicado 2022

Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer

por Winn, Aaron N., Check, Devon K., Farkas, Amy, Fergestrom, Nicole M., Neuner, Joan M., Roberts, Andrew W.
Publicado 2020

North Carolina Medicaid Recipient Management Lock-In Program: The Pharmacist’s Perspective

por Werth, S. Rose, Sachdeva, Nidhi, Roberts, Andrew W., Garrettson, Mariana, Ringwalt, Chris, Moss, Leslie A., Pikoulas, Theodore, Skinner, Asheley Cockrell
Publicado 2014

Structural Basis for Apoptosis Inhibition by Epstein-Barr Virus BHRF1

por Kvansakul, Marc, Wei, Andrew H., Fletcher, Jamie I., Willis, Simon N., Chen, Lin, Roberts, Andrew W., Huang, David C. S., Colman, Peter M.
Publicado 2010

Predictors of Chronic Opioid Use: A Population-Level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims

por Check, Devon K, Baggett, Christopher D, Kim, KyungSu, Roberts, Andrew W, Roberts, Megan C, Robinson, Timothy, Oeffinger, Kevin C, Dinan, Michaela A
Publicado 2021

Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells

por Ushiki, Takashi, Huntington, Nicholas D., Glaser, Stefan P., Kiu, Hiu, Georgiou, Angela, Zhang, Jian-Guo, Metcalf, Donald, Nicola, Nicos A., Roberts, Andrew W., Alexander, Warren S.
Publicado 2016

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach

por Arber, Daniel A., Hasserjian, Robert P., Orazi, Attilio, Mathews, Vikram, Roberts, Andrew W., Schiffer, Charles A., Roug, Anne Stidsholt, Cazzola, Mario, Döhner, Hartmut, Tefferi, Ayalew
Publicado 2022

Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy

por Handunnetti, Sasanka, Anderson, Mary Ann, Roberts, Andrew W., Davids, Matthew S., Ma, Shuo, Boyer, Michelle, Arzt, Jennifer, Masud, Abdullah Al, Popovic, Relja, Jacobson, Amanda, Kim, Su Y., Seymour, John F.
Publicado 2021

IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3

por Croker, Ben A, Kiu, Hiu, Pellegrini, Marc, Toe, Jesse, Preston, Simon, Metcalf, Donald, O’Donnell, Joanne A, Cengia, Louise H, McArthur, Kate, Nicola, Nicos A, Alexander, Warren S, Roberts, Andrew W
Publicado 2011

Shielding the Vulnerable: A Multicentre Australian Rollout of Evusheld to Patients with Chronic Lymphocytic Leukaemia (CLL-SHIELD)

por Whitechurch, Ashley, Bennett, Rory, Inam, Shafqat, Hartog, Benjamin, Blackwood, Rebecca, Fernando, Shevon, Hutani, Felanita, Bortz, Hadley, Lincoln, Mitchel, Carney, Dennis, Roberts, Andrew W, Anderson, Mary Ann, Tam, Constantine S., Seymour, John F.
Publicado 2022

Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six...

por Gopalakrishnan, Sathej, Menon, Rajeev, Suleiman, Ahmed A., Kater, Arnon P., Stilgenbauer, Stephan, Seymour, John F., Chyla, Brenda, Lu, Tong, Young Kim, Su, Roberts, Andrew W., Woyach, Jennifer A., Mensing, Sven, Salem, Ahmed Hamed
Publicado 2023

Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors

por Thompson, Ella R., Nguyen, Tamia, Kankanige, Yamuna, Markham, John F., Anderson, Mary Ann, Handunnetti, Sasanka M., Thijssen, Rachel, Yeh, Paul Sung-Hao, Tam, Constantine S., Seymour, John F., Roberts, Andrew W., Westerman, David A., Blombery, Piers
Publicado 2022

Long-term Follow-up of Patients with Relapsed or Refractory Non–Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study

por Davids, Matthew S., Roberts, Andrew W., Kenkre, Vaishalee P., Wierda, William G., Kumar, Abhijeet, Kipps, Thomas J., Boyer, Michelle, Salem, Ahmed Hamed, Pesko, John C., Arzt, Jennifer A., Mantas, Margaret, Kim, Su Y., Seymour, John F.
Publicado 2021

Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition

por Lew, Thomas E., Lin, Victor S., Cliff, Edward R., Blombery, Piers, Thompson, Ella R., Handunnetti, Sasanka M., Westerman, David A., Kuss, Bryone J., Tam, Constantine S., Huang, David C. S., Seymour, John F., Roberts, Andrew W., Anderson, Mary Ann
Publicado 2021

Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations

por Birkinshaw, Richard W., Gong, Jia-nan, Luo, Cindy S., Lio, Daisy, White, Christine A., Anderson, Mary Ann, Blombery, Piers, Lessene, Guillaume, Majewski, Ian J., Thijssen, Rachel, Roberts, Andrew W., Huang, David C. S., Colman, Peter M., Czabotar, Peter E.
Publicado 2019

Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets

por Josefsson, Emma C., James, Chloé, Henley, Katya J., Debrincat, Marlyse A., Rogers, Kelly L., Dowling, Mark R., White, Michael J., Kruse, Elizabeth A., Lane, Rachael M., Ellis, Sarah, Nurden, Paquita, Mason, Kylie D., O’Reilly, Lorraine A., Roberts, Andrew W., Metcalf, Donald, Huang, David C.S., Kile, Benjamin T.
Publicado 2011